Concurrent Chemoradiotherapy with Daily Low-Dose Carboplatin in Older Patients with Unresectable Locally Advanced Non-Small-Cell Lung Cancer: Clinical Outcomes and Prognostic Significance of Systemic Inflammation Markers

Older patients with unresectable locally advanced non-small-cell lung cancer (NSCLC) frequently receive concurrent chemoradiotherapy (CCRT) with daily low-dose carboplatin; however, real-world data on its efficacy, safety, and prognostic factors remain limited. We aimed to retrospectively evaluate t...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Yu Miura, Hisao Imai, Satoshi Endo, Kosuke Hashimoto, Ou Yamaguchi, Atsuto Mouri, Ken Masubuchi, Takeshi Masubuchi, Yuka Fujita, Shingo Kato, Hiroshi Kagamu, Kyoichi Kaira
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	MDPI AG 2026-02-01
Ráidu:	Current Oncology
Fáttát:	chemoradiotherapy efficacy Glasgow Prognostic Score low-dose carboplatin non-small-cell lung cancer
Liŋkkat:	https://www.mdpi.com/1718-7729/33/3/135
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!